Tandem autologous plus non-myeloablative allogeneic stem cell transplantation in relapsed multiple myeloma: an Australian joint report from the Alfred and Myeloma and Related Diseases Registry

被引:0
|
作者
Tedjaseputra, Aditya [1 ]
Das, Tongted [1 ]
Wellard, Cameron [2 ]
Spencer, Andrew [3 ]
机构
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Transfus Res Unit, Clayton, Vic, Australia
[3] Monash Univ, Alfred Hlth, Clayton, Vic, Australia
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-218
引用
收藏
页码:S159 / S160
页数:2
相关论文
共 50 条
  • [1] Non-myeloablative allogeneic transplantation in patients with relapsed or refractory multiple myeloma.
    Gerull, S
    Hegenbart, U
    Goerner, M
    Benner, A
    Moehler, T
    Goldschmidt, H
    Ho, AD
    BLOOD, 2004, 104 (11) : 755A - 755A
  • [2] NON-MYELOABLATIVE CONDITIONING AND ALLOGENEIC TRANSPLANTATION FOR MULTIPLE MYELOMA
    Osman, K.
    Elliott, B.
    Mandeli, J.
    Scigliano, E.
    Ross-Dodds, V.
    Isola, L.
    Grosskreutz, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 71 - 71
  • [3] Salvage non-myeloablative allogeneic transplantation after failure of an autologous transplantation in multiple myeloma
    Qazilbash, MH
    Saliba, R
    Mendoza, F
    Roden, L
    Hosing, C
    Couriel, DE
    Kebriaci, W
    Popat, U
    De Lima, M
    Champlin, RE
    Giralt, SA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 117 - 117
  • [4] Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma
    Osman, Keren
    Elliott, Brian
    Mandeli, John
    Scigliano, Eileen
    Malone, Adriana
    Isola, Luis
    Grosskreutz, Celia
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (04) : 249 - 254
  • [5] Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
    F Garban
    M Attal
    JF Rossi
    C Payen
    N Fegueux
    JJ Sotto
    Leukemia, 2001, 15 : 642 - 646
  • [6] Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
    Garban, F
    Attal, M
    Rossi, JF
    Payen, C
    Fegueux, N
    Sotto, JJ
    LEUKEMIA, 2001, 15 (04) : 642 - 646
  • [7] Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
    L Karlin
    B Arnulf
    S Chevret
    L Ades
    M Robin
    R P De Latour
    M Malphettes
    N Kabbara
    B Asli
    V Rocha
    J P Fermand
    G Socie
    Bone Marrow Transplantation, 2011, 46 : 250 - 256
  • [8] Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
    Karlin, L.
    Arnulf, B.
    Chevret, S.
    Ades, L.
    Robin, M.
    De Latour, R. P.
    Malphettes, M.
    Kabbara, N.
    Asli, B.
    Rocha, V.
    Fermand, J. P.
    Socie, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 (02) : 250 - 256
  • [9] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    P Campbell
    P Walker
    S Avery
    S Patil
    D Curtis
    A Schwarer
    A Wei
    A Kalff
    J Muirhead
    A Spencer
    Blood Cancer Journal, 2014, 4 : e213 - e213
  • [10] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    Campbell, P.
    Walker, P.
    Avery, S.
    Patil, S.
    Curtis, D.
    Schwarer, A.
    Wei, A.
    Kalff, A.
    Muirhead, J.
    Spencer, A.
    BLOOD CANCER JOURNAL, 2014, 4 : e213 - e213